TY - JOUR
T1 - Expression in Aspergillus niger of the Starch‐Binding Domain of Glucoamylase
T2 - Comparison with the Proteolytically Produced Starch‐Binding Domain
AU - Le Gal‐Coëffet, Marie‐Françoise ‐F
AU - Jacks, Amanda J.
AU - Sorimachi, Kay
AU - Williamson, Michael P.
AU - Williamson, Gary
AU - Archer, David B.
PY - 1995/1/1
Y1 - 1995/1/1
N2 - Glucoamylase 1 from Aspergillus niger is an economically important enzyme in many industrial processes. It hydrolyses granular starch and comprises two distinct domains, a catalytic and a starch‐binding domain (SBD). We have transformed A. niger with an expression vector for the secretion of SBD for physicochemical studies. This was achieved by introducing into the glucoamylase gene a short sequence encoding an endoproteolytic cleavage recognition site such that free SBD was secreted at yields up to 200 mg/1. Free SBD was also obtained by proteolytic digestion of full‐length glucoamylase 1. Electrospray mass spectroscopy was used to determine the carbohydrate content of both SBDs. It revealed that the engineered one is more glycosylated: an average of three mannose residues compared to one for the proteolytically derived SBD. Sequencing results also suggest partial glycosylation for the three Thr residues involved (510, 511, 513). It is probable that the engineered SBD represents the true glycosylation level of the SBD in native glucoamylase. Binding of β‐cyclodextrin to the SBD was investigated. It was found that the stoichiometry and the spectral perturbation of Trp residues were identical for both SBDs, but the engineered SBD bound less strongly to the ligand. At high concentrations of β‐cyclodextrin relative to the estimated Kd values, the maximum absorbance changes were identical. The observed difference at low β‐cyclodextrin levels was probably due to the higher level of glycosylation of the expressed SBD. We conclude that the proteolytically derived and expressed starch binding domains both bind 2 mol β‐cyclodextrin/mol protein, but that the pattern of glycosylation and strength of binding are different.
AB - Glucoamylase 1 from Aspergillus niger is an economically important enzyme in many industrial processes. It hydrolyses granular starch and comprises two distinct domains, a catalytic and a starch‐binding domain (SBD). We have transformed A. niger with an expression vector for the secretion of SBD for physicochemical studies. This was achieved by introducing into the glucoamylase gene a short sequence encoding an endoproteolytic cleavage recognition site such that free SBD was secreted at yields up to 200 mg/1. Free SBD was also obtained by proteolytic digestion of full‐length glucoamylase 1. Electrospray mass spectroscopy was used to determine the carbohydrate content of both SBDs. It revealed that the engineered one is more glycosylated: an average of three mannose residues compared to one for the proteolytically derived SBD. Sequencing results also suggest partial glycosylation for the three Thr residues involved (510, 511, 513). It is probable that the engineered SBD represents the true glycosylation level of the SBD in native glucoamylase. Binding of β‐cyclodextrin to the SBD was investigated. It was found that the stoichiometry and the spectral perturbation of Trp residues were identical for both SBDs, but the engineered SBD bound less strongly to the ligand. At high concentrations of β‐cyclodextrin relative to the estimated Kd values, the maximum absorbance changes were identical. The observed difference at low β‐cyclodextrin levels was probably due to the higher level of glycosylation of the expressed SBD. We conclude that the proteolytically derived and expressed starch binding domains both bind 2 mol β‐cyclodextrin/mol protein, but that the pattern of glycosylation and strength of binding are different.
KW - Aspergillus niger
KW - carbohydrate binding
KW - glucoamylase 1
KW - heterologous expression
KW - starch‐binding domain
UR - http://www.scopus.com/inward/record.url?scp=0028850651&partnerID=8YFLogxK
U2 - 10.1111/j.1432-1033.1995.561_2.x
DO - 10.1111/j.1432-1033.1995.561_2.x
M3 - Article
C2 - 7588802
AN - SCOPUS:0028850651
SN - 0014-2956
VL - 233
SP - 561
EP - 567
JO - European Journal of Biochemistry
JF - European Journal of Biochemistry
IS - 2
ER -